Uploaded November 2025 | Updated September 2026, 13 minutes ago

---

You may know Ozempic or Wegovy, but did you know Daniel Drucker’s groundbreaking work on glucagon-like peptide-1 (GLP-1) is what makes them possible?

Daniel Drucker, physician, senior investigator at the Lunenfeld-Tanenbaum Research Institute at @SinaiHealth University Professor at @UofTMed is one of the five researchers who uncovered the science behind GLP-1. The groundbreaking research has transformed millions of lives with new treatments for diabetes and weight loss, and shows huge promise in treating a wide array of other conditions, from kidney disease to neurological disorders.

Learn more about Drucker’s award-winning work at uoft.me/dan-drucker